Spero Therapeutics, Inc. (SPRO) Earning

$0.83

south_east
-$0.01 (-0.68%)
Day's range
$0.81
Day's range
$0.84
SPRO Earnings Estimates and Actuals by Quarter$1$1$0$0-$1-$1-$2-$2Q1 2021Q1 2021Q3 2021Q3 2021Q1 2022Q1 2022Q3 2022Q3 2022Q1 2023Q1 2023Q3 2023Q3 2023Q1 2024Q1 2024Q3 2024Q3 2024Q1 2025Q1 2025Q3 2025Q3 2025
Actual EPS
Download SVG
Download PNG
Download CSV

Spero Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 1 -$0.27 -$0.27 -$0.27
Q2 2025 1 -$0.25 -$0.25 -$0.25
Q3 2025 1 -$0.22 -$0.22 -$0.22
Q4 2025 1 -$0.10 -$0.10 -$0.10

Spero Therapeutics, Inc. Earnings Date And Information

Spero Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.27 by $0.05. The company had revenue of 7.82 M for the quarter and had revenue of 96.74 M for the year. Spero Therapeutics, Inc. has generated $0 earnings per share over the last year ($0.43 diluted earnings per share) and currently has a price-to-earnings ratio of 15.34. Spero Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.

Spero Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/14/2024 Q3 2024 -$0.27 -$0.33 -0.06 $23.00 M $7.82 M
08/05/2024 Q2 2024 -$0.35 -$0.33 0.02 $4.90 M $6.02 M
05/15/2024 Q1 2024 -$0.07 -$0.24 -0.17 N/A $4.20 M
03/13/2024 Q4 2023 -$0.10 $0.97 1.07 N/A $71.83 M
11/13/2023 Q3 2023 -$0.15 -$0.06 0.09 $14.97 M $25.47 M
08/10/2023 Q2 2023 -$0.29 -$0.23 0.06 $1.08 M $788,000
05/11/2023 Q1 2023 N/A -$0.23 N/A N/A $740,000
03/30/2023 Q4 2022 -$0.40 $0.55 0.95 N/A $46.30 M
11/14/2022 Q3 2022 -$0.34 -$0.33 0.01 $5.42 M $1.08 M
08/10/2022 Q2 2022 -$0.88 -$0.87 0.01 $1.43 M $896,000
05/16/2022 Q1 2022 N/A -$1.09 N/A N/A $247,000
03/31/2022 Q4 2021 -$0.80 -$0.91 -0.11 N/A $2.74 M
11/10/2021 Q3 2021 -$0.70 -$0.70 0 $4.47 M $3.06 M
08/05/2021 Q2 2021 -$0.77 -$0.63 0.14 $4.53 M $5.15 M
05/06/2021 Q1 2021 -$0.61 -$0.66 -0.05 N/A $7.30 M
03/11/2021 Q4 2020 -$0.77 -$0.68 0.09 N/A $1.91 M
11/05/2020 Q3 2020 -$0.91 -$0.86 0.05 $3.01 M $4.00 M
08/06/2020 Q2 2020 -$1.17 -$0.85 0.32 $3.31 M $1.73 M
05/08/2020 Q1 2020 -$1.35 -$1.19 0.16 N/A $169,000
03/16/2020 Q4 2019 -$1.09 -$1.32 -0.23 N/A $696,000

Spero Therapeutics, Inc. Earnings: FAQ's

Spero Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based offlast year's report dates.

The conference call for Spero Therapeutics, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Spero Therapeutics, Inc.'s latest earnings report can be read online.

Spero Therapeutics, Inc. (:SPRO) has a recorded annual revenue of $96.74 M.

Spero Therapeutics, Inc. (:SPRO) has a recorded net income of $22.81 M.Spero Therapeutics, Inc. has generated $0.43 earnings per share over the last four quarters.

Spero Therapeutics, Inc. (:SPRO) has a price-to-earnings ratio of 15.34 and price/earnings-to-growth ratio is -0.19.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED